Fixed Dose Comparison of Escitalopram to an Active Comparator in Severely Depressed Patients
NCT00384436 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 580
Last updated 2008-01-07
Summary
The purpose of this study is to evaluate the safety and efficacy of escitalopram to an active comparator in severely depressed patients
Conditions
Interventions
- DRUG
-
escitalopram
Sponsors & Collaborators
-
Forest Laboratories
lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2006-10-31
- Primary Completion
- 2007-10-31
Countries
- United States
Study Locations
More Related Trials
-
Medications for the Treatment of Dysthymic Disorder and Double Depression
NCT00234312 ·Status: COMPLETED ·Phase: PHASE4
-
Escitalopram in the Treatment of Dysthymic Disorder, Double Blind
NCT00220701 ·Status: COMPLETED ·Phase: PHASE4
-
Study of Escitalopram in Adult Patients With Major Depressive Disorder
NCT00108979 ·Status: COMPLETED ·Phase: PHASE3
-
A Trial Evaluating the Efficacy and Tolerability of SSR125543 in Outpatients With Major Depressive Disorder
NCT01034995 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Tolerability of Escitalopram and Duloxetine in Outpatients With Major Depressive Disorder
NCT01148472 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Safety of SR58611A co-Administered With Escitalopram in Adults With Major Depressive Disorder
NCT00432614 ·Status: COMPLETED ·Phase: PHASE3
-
An Eight-Week Study Evaluating the Efficacy and Tolerability of Two Doses of SSR149415 in Outpatients With Major Depressive Disorder
NCT00358631 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate the Impact of Escitalopram on Quality of Life and Social Functionality in Patients With Major Depressive Disorder With Anxiety Symptom
NCT01870843 ·Status: COMPLETED ·Phase: PHASE4
-
Adherence to Antidepressant Treatment in Subjects With Depression
NCT03388164 ·Status: TERMINATED ·Phase: PHASE2
-
Brain Activity Changes and Treatment Response in Depressed People Who Are Receiving Antidepressant Medication
NCT00375843 ·Status: COMPLETED ·Phase: PHASE4
-
An Eight-week Study Evaluating the Efficacy of a 100mg Dose of Saredutant Once Daily, in Elderly Patients With Major Depressive Disorder
NCT00415142 ·Status: COMPLETED ·Phase: PHASE3
-
Continuation Electroconvulsive Therapy Vs Medication to Prevent Relapses in Patients With Major Depressive Disorder
NCT00000375 ·Status: COMPLETED ·Phase: PHASE4
-
Dose-Finding Clinical Trial to Evaluate the Efficacy and Safety of LV232 Capsules in the Treatment of MDD
NCT06828887 ·Status: RECRUITING ·Phase: PHASE2
-
A Study to Test Different Doses of BI 1569912 in People With Depression
NCT06558344 ·Status: COMPLETED ·Phase: PHASE2
-
A Study for Participants With Major Depression
NCT00420004 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of SR58611A in Patients With Major Depressive Disorder
NCT00252330 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of SR58611A in Patients With Major Depressive Disorder
NCT00252356 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety Study of ABT-436 in Major Depressive Disorder
NCT01741142 ·Status: TERMINATED ·Phase: PHASE2
-
Early Versus Delayed Switch in Medication in Patients With Major Depressive Disorder
NCT00810069 ·Status: COMPLETED ·Phase: PHASE4
-
An Efficacy and Safety Study of Escitalopram Long-Term Treatment in Major Depressive Disorder With Associated Anxiety Symptoms
NCT01814098 ·Status: COMPLETED ·Phase: PHASE4
-
Escitalopram as a Mood Stabilizer for Bipolar II Disorder
NCT00156325 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of Patients With Major Depressive Disorder and Residual Apathy
NCT00985504 ·Status: COMPLETED ·Phase: PHASE4
-
The Safety and Efficacy of Escitalopram in Pediatric Patients With Major Depressive Disorder
NCT00107120 ·Status: COMPLETED ·Phase: PHASE3
-
To Assess the Safety and Tolerability of an Oral Aripiprazole/Escitalopram Combination Therapy in Participants With Major Depressive Disorder (MDD)
NCT01123707 ·Status: TERMINATED ·Phase: PHASE3
-
Neurotrophic Factors and Depression
NCT00812994 ·Status: COMPLETED ·Phase: PHASE4